Clinical Trial: Reappraisal of Atrial Fibrillation: Interaction Between HyperCoagulability, Electrical Remodeling, and Vascular Destabilisation in the Progression of Atrial Fibrillation
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational
Official Title: Reappraisal of Atrial Fibrillation: Interaction Between HyperCoagulability, Electrical Remodeling, and Vascular Destabilisation in the Progression of Atrial Fibrillation -
Brief Summary: The purpose of this study is to study clinical factors and (blood) biomarkers related to progression of Atrial Fibrillation (AF) in patients diagnosed with self-terminating AF with special reference to hypercoagulability. All patients will be continuously monitored for their atrial rhythm to assess AF progression, either through an implantable loop recorder (Reveal LinQ) or via the atrial lead of a cardiac implantable electronic device (CIED), both in combination with the CareLink home monitoring system. Remote monitoring and interrogation will be installed and used on a daily basis.
Detailed Summary:
Sponsor: Maastricht University Medical Center
Current Primary Outcome: Progression of AF burden [ Time Frame: 2.5 years ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Major Adverse Cardiac and Cerebrovascular Events [ Time Frame: 2.5 years ]
- Change in therapy due to continuous rhythm monitoring with the LinQ/Carelink system [ Time Frame: 2.5 years ]
Original Secondary Outcome: Same as current
Information By: Maastricht University Medical Center
Dates:
Date Received: March 17, 2016
Date Started: July 2016
Date Completion: October 2020
Last Updated: October 19, 2016
Last Verified: July 2016
